Skip to main content
. 2021 Jul 6;40(33):5204–5212. doi: 10.1038/s41388-021-01928-w

Fig. 3. Comparative analysis of cfDNA mutations and their concordance with corresponding tissue samples.

Fig. 3

Patients were assigned to a sub-group based on A high-input and B low-input cfDNA samples used for NGS analysis (≥30 and <30 ng, respectively). FIC Ficoll-enriched CTCs, LB liquid biopsy, LR local recurrence, NGS next-generation sequencing, ROS RosetteSep™-enriched CTCs, tDNA tumor-derived DNA.